'Single digit million dollar financial milestone payment'- That ought to buy them at least a few months.
Also, do not forget that PRR also has the monthly equity funding USD700k-1.5m from Bergen.
I reckon PRR can survive, and everyone have to swallow the bitter pill right now. As we all know, such micro-biotech companies burn cash really quick, but as long as they can meet their cashflow, it should pay off when they have a breakthrough.
However, directors and officials of the company have to show confidence in the company to keep us SH confident of their intentions.
Ann: Introductory Investor Presentation, page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.0¢ | $732.3K | 2.454M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 113261 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 169614 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |